Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancerXinyi Guo, Yicheng Zhu, Xiaohong Zhao et al.|Cancer Cell|2025Cited by 65